2019

Nytko KJ, Thumser-Henner P, Weyland MS, Scheidegger S, Bley CR
Cell line-specific efficacy of thermoradiotherapy in human and canine cancer cells in vitro.
PLoS One. 2019 May 15;14(5):e0216744
PubMed Group Rohrer Bley

Piccinini AL, Golan O, Torres-Netto EA, Hafezi F, Randleman JB
Corneal higher-order aberrations measurements: Comparison between Scheimpflug and dual Scheimpflug-Placido technology in keratoconic eyes.
J Cataract Refract Surg. 2019 Apr 24 [Epub ahead of print]

PubMed Group Hafezi

Webb JN, Langille E, Hafezi F, Randleman JB, Scarcelli G
Biomechanical Impact of Localized Corneal Cross-linking Beyond the Irradiated Treatment Area.
J Refract Surg. 2019 Apr 1;35(4):253-260

PubMed Group Hafezi

Piccinini AL, Golan O, Hafezi F, Randleman JB
Higher-order aberration measurements: Comparison between Scheimpflug and dual Scheimpflug-Placido technology in normal eyes.
J Cataract Refract Surg. 2019 Apr;45(4):490-494

PubMed Group Hafezi

Lang PZ, Hafezi NL, Khandelwal SS, Torres-Netto EA, Hafezi F, Randleman JB
Comparative Functional Outcomes After Corneal Crosslinking Using Standard, Accelerated, and Accelerated With Higher Total Fluence Protocols.
Cornea. 2019 Apr;38(4):433-441

PubMed Group Hafezi

Torres Netto EA, Randleman JB, Hafezi NL, Hafezi F
Late-onset progression of keratoconus after therapy with selective estrogenic activity regulator.
J Cataract Refract Surg. 2019 Jan;45(1):101-104

PubMed Group Hafezi

Deshmukh R, Hafezi F, Kymionis GD, Kling S, Shah R, Padmanabhan P, Sachdev MS
Current concepts in crosslinking thin corneas.
Indian J Ophthalmol. 2019 Jan;67(1):8-15

PubMed Group Hafezi